STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 55 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $12,000 | +9.1% | 4,375 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | +22.2% | 4,375 | 0.0% | 0.00% | – |
| Q3 2020 | $9,000 | -60.9% | 4,375 | -26.6% | 0.00% | – |
| Q2 2020 | $23,000 | +228.6% | 5,957 | +54.5% | 0.00% | – |
| Q1 2020 | $7,000 | -46.2% | 3,855 | -36.2% | 0.00% | – |
| Q4 2019 | $13,000 | -7.1% | 6,045 | 0.0% | 0.00% | – |
| Q3 2019 | $14,000 | -26.3% | 6,045 | 0.0% | 0.00% | – |
| Q2 2019 | $19,000 | -52.5% | 6,045 | +31.8% | 0.00% | – |
| Q1 2018 | $40,000 | +21.2% | 4,587 | 0.0% | 0.00% | – |
| Q4 2017 | $33,000 | +50.0% | 4,587 | +44.2% | 0.00% | – |
| Q3 2017 | $22,000 | -4.3% | 3,181 | 0.0% | 0.00% | – |
| Q2 2017 | $23,000 | – | 3,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |